DOCSLIB.ORG

Downloaded for Personal Use Only

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Downloaded for Personal Use Only Reviews 203 Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity Authors Ming Tsuen Hsieh 1, Wen Huang Peng1, Chi Rei Wu1, Kit Ying Ng2, Chuen Lung Cheng2, Hong Xi Xu2 Affiliations 1 Graduate Institute of Chinese Pharmaceutical Sciences, College of Pharmacy, China Medical University, Taichung, Taiwan 2 Hong Kong Jockey Club Institute of Chinese Medicine, Hong Kong, Peopleʼs Republic of China Key words Abstract AChE: acetylcholinesterase l" amnesia ! AD: Alzheimerʼs disease l" herbal medicines Amnesia is characterized by the inability to form AGR: Acori graminei Soland., Araceae rhi- l" cholinergic system memories or total or partial loss of memory sec- zome l" GABAergic system ondary to cerebral malfunction following degen- AMPA: alpha-amino-3-hydroxy-5-methyl- l" glutaminergic system l" memory enhancement erative diseases, cerebral infections, traumatic in- 4-isoxazolepropionic acid juries and emotional events which could be dif- BBB: blood-brain barrier ferentiated from dementia. However, no effective BDPH: n-butylidenephthalide treatment for amnesia is currently available. cDNA: complimentary deoxyribonucleic Much research effort has been focused on devel- acid oping new drugs from herbal medicines which ChAT choline-acetyltransferase have multifunctional properties. Novel plant ex- CNS: central nervous system tracts and their major or bioactive components E‑p-MCA: E‑p-methoxycinnamic acid including alkaloids, flavonoids, glycosides and FDA: Food and Drug Administration saponins with promising antioxidant effects, vari- GABA: gamma-aminobutyric acid ous effects on cholinergic, GABAergic, glutami- GBE: Ginkgo biloba L., Ginkgoaceae extract nergic, serotonergic, catecholaminergic and hista- GSH: glutathione minergic systems, enhancement of cerebral blood HBA: p-hydroxybenzyl alcohol flow and elevation of ribonucleic acid (RNA) as LDW: Liuwei Dihuang Wang well as protein levels have been studied. In this LTP: long-term potentiation review, we discuss the research findings on novel MAO: monoamine oxidase received August 21, 2009 plant extracts and their bioactives with anti-am- MCA‑Hg: 8-O‑E‑p-methoxycinnamoylharpa- revised October 7, 2009 nesic effects on different neurotransmitter sys- gide accepted Nov. 20, 2009 tems. Developing new drugs from herbal medi- MDA: malondialdehyde Bibliography cines for the treatment of amnesia is a hopeful at- NMDA: N-methyl-D-aspartic acid DOI http://dx.doi.org/ tempt to meet the unmet medical needs. PD/PT ratio: protopanaxadiol/protopanaxatriol 10.1055/s-0029-1240707 ratio This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. Published online December 23, 2009 RGTS: red ginseng total saponins Planta Med 2010; 76: 203–217 Abbreviations RNA: ribonucleic acid © Georg Thieme Verlag KG ! RT‑PCR: reverse transcriptase polymerase Stuttgart · New York · 5,7-DHT: 5,7-dihydrotroptamine chain reaction ISSN 0032‑0943 5-HT: serotonin SOD: superoxide dismutase Correspondence 6-OHDA: 6-hydroxydopamine TBARS: thiobarbituric acid reactive species Dr. Hong Xi Xu ACh: acetylcholine Hong Kong Jockey Club Institute of Chinese Medicine Unit 703, 7/F Bio-Informatics Centre Introduction cerebral infections such as herpes or encephalitis, Hong Kong Science Park ! Shatin traumatic injuries such as stroke, alcohol or drug Hong Kong Amnesia is characterized by the inability to form abuse and emotional events such as psychological Peopleʼs Republic of China memories or total or partial loss of memory sec- trauma. The limbic system, comprised of the hip- Phone: + 85234062873 Fax: + 852 35517333 ondary to cerebral malfunction following degen- pocampus, amygdala and parts of the cortex, is [email protected] erative diseases such as Alzheimerʼs disease (AD), responsible for retrieving memory. Memory for- Hsieh MT et al. Review on Experimental … Planta Med 2010; 76: 203–217 204 Reviews mation can be broadly categorized into three distinctive stages, hance the activity of active components from other herbs in ac- namely learning acquisition, memory consolidation and retriev- cordance with traditional practices including traditional Chinese al. Despite the extensive causes of amnesia, the major affected and Ayurvedic medicines. brain regions are usually the subcortical region called the dience- Herbal medicines may confer anti-amnesic protection by scav- phalon and the cortical region called the medial temporal lobe enging free radicals, enhancing cerebral blood flow, restoring ri- [1]. The definition of amnesia can vary considerably according to bonucleic acid (RNA) and protein levels. Besides, neurotransmit- different agreements on the term. This review focuses on recent ter systems were shown to play pivotal roles in cognitive pro- literature on anterograde amnesia, which is the impaired ability cesses where interactions between systems give rise to memory to learn new information following the onset of amnesia, and ret- formation, consolidation and retrieval. Meanwhile, deficits in rograde amnesia, which is the impaired ability to recall past cholinergic, GABAergic, glutaminergic, serotonergic, catechola- events and previously familiar information. Although amnesia is minergic and histaminergic neurotransmissions can account at easily confused with dementia, they are distinguishable from least partly for the pathophysiology of amnesia. Long-term po- each other. Unlike dementia, the amnesic memory loss does not tentiation is an important process in learning and memory, the affect a personʼs intelligence, general knowledge, awareness, at- action of which can be affected by changes in cholinergic, dopa- tention span, judgment, personality or identity. Amnesia can minergic, noradrenergic and serotonergic systems [8–12]. Nu- happen to people at any age which can be a heavy burden to fam- merous research findings have revealed the involvement of ily members and the society, and requires extensive medical care different neurotransmitters in memory processes. Glutamate, and support schemes. GABA, dopamine and acetylcholine were shown to have stronger No conventional or alternative therapy is currently available to impacts on cognitive processes than serotonin and norepineph- cure amnesia. Current therapeutic strategies for amnesia are rine [13]. As reported in a number of experimental paradigms, mainly focused on enhancing or restoring cerebral circulation, re- administration of NMDA antagonists like MK-801and APV, AMPA storing the level of neurotransmitters including acetylcholine antagonists like NBQX and CNQX, GABAA agonists like diazepam (ACh), scavenging free radicals and restoring cell membrane flu- and muscimol, GABAB antagonist (CGP 464 381) and agonist (ba- idity. In the management of amnesia as well as AD, sustained clofen), muscarinic antagonists like scopolamine and atropine, treatment with cholinesterase inhibitors including donepezil, ri- nicotinic antagonist like mecamylamine, serotonin 5-HT1A ago- vastigmine, galantamine and tacrine have been used. However, nist like alaproclate and buspirone, norepinephrine α‑1 antago- these drugs have questionable efficacy and may induce severe nist like prazosin, α‑2 agonist like dexmedetomidine and a β an- side effects including nausea, vomiting, diarrhea and muscle tagonist like propranolol, and dopamine D-2 antagonists like hal- cramps. operidol and sulpiride led to memory impairment, while the uses Since ancient times, herbal medicines have been documented of AMPA agonist like piperidine and norepinephrine α‑1 agonist and used for nootropics (cognition-enhancing agents which aim like St-587 resulted in memory enhancement [13]. at improving concentration, memory retention and problem- The literature was retrieved by searches of the most popular da- solving ability). In China, for example, the use of Panax ginseng tabase Pubmed, using different combinations of keywords in- C.A. Meyer (Araliaceae) to promote health and improve learning cluding “herbs”, “herbal medicines”, “amnesia”, “memory en- and memory is well documented [2–4]. Nowadays, Ginkgo biloba hancement”, “anti-oxidant”, “cholinergic”, “GABAergic”, “gluta- L. (Ginkgoaceae) extract (GBE) has been widely used as a health minergic”, “serotonergic”, “catecholaminergic” and “histaminer- supplement to promote memory and standardized GBE has been gic”. The search covered the period from 1983 to March 2009. Re- approved in the German Commission E Monograph for the symp- views and research articles related to retrograde and anterograde tomatic treatment of the memory impairment, concentration amnesia were included. Additional papers of interest were re- difficulties and depression that result from organic brain disease trieved from the reference lists of the above articles. We man- [5]. In the past few years, the uses of herbal medicines for the ually retrieved some recognized articles which are not available treatment of cognitive impairments such as amnesia, AD or de- electronically. To construct a meaningful discussion on anti-am- mentia have been widely studied; some drugs developed from nesic effect of herbal medicine, studies totally without any at- herbs have shown prominent clinical improvements. A good ex- tempt at mechanistic elucidation were excluded. ample is galantamine (also known as galanthamine), which is an This paper summarizes the research findings and provides an alkaloid extracted from the bulbs of Galanthus nivalis L. (Amaryl- overview of herbal medicines as treatments for both retrograde lidaceae) with a promising effect
Load more

Recommended publications
  • Redox Signaling and Alzheimer's Disease
    Chen et al. Biomarker Research (2020) 8:42 https://doi.org/10.1186/s40364-020-00218-z REVIEW Open Access Redox signaling and Alzheimer’s disease: from pathomechanism insights to biomarker discovery and therapy strategy Yuan-Yuan Chen1†, Min-Chang Wang2†, Yan-Ni Wang1, He-He Hu1, Qing-Quan Liu3*, Hai-Jing Liu4* and Ying-Yong Zhao1* Abstract Aging and average life expectancy have been increasing at a rapid rate, while there is an exponential risk to suffer from brain-related frailties and neurodegenerative diseases as the population ages. Alzheimer’s disease (AD) is the most common neurodegenerative disease worldwide with a projected expectation to blossom into the major challenge in elders and the cases are forecasted to increase about 3-fold in the next 40 years. Considering the etiological factors of AD are too complex to be completely understood, there is almost no effective cure to date, suggesting deeper pathomechanism insights are urgently needed. Metabolites are able to reflect the dynamic processes that are in progress or have happened, and metabolomic may therefore provide a more cost-effective and productive route to disease intervention, especially in the arena for pathomechanism exploration and new biomarker identification. In this review, we primarily focused on how redox signaling was involved in AD-related pathologies and the association between redox signaling and altered metabolic pathways. Moreover, we also expatiated the main redox signaling-associated mechanisms and their cross-talk that may be amenable to mechanism-based therapies. Five natural products with promising efficacy on AD inhibition and the benefit of AD intervention on its complications were highlighted as well.
    [Show full text]
  • Authentication and Genetic Origin of Medicinal Angelica Acutiloba Using Random Amplified Polymorphic DNA Analysis
    American Journal of Plant Sciences, 2013, 4, 269-273 http://dx.doi.org/10.4236/ajps.2013.42035 Published Online February 2013 (http://www.scirp.org/journal/ajps) Authentication and Genetic Origin of Medicinal Angelica acutiloba Using Random Amplified Polymorphic DNA Analysis Kiyoshi Matsubara*, Satoshi Shindo, Hitoshi Watanabe, Fumio Ikegami Center for Environment, Health and Field Sciences, Chiba University, Kashiwa, Japan. Email: *[email protected] Received December 18th, 2012; revised January 15th, 2013; accepted January 22nd, 2013 ABSTRACT Some Angelica species are used for medicinal purposes. In particular, the roots of Angelica acutiloba var. acutiloba and A. acutiloba var. sugiyamae, known as “Toki” and “Hokkai Toki”, respectively, are used as important medicinal materi- als in traditional Japanese medicine. However, since these varieties have recently outcrossed with each other, it is diffi- cult to determine whether the Japanese Angelica Root material used as a crude drug is the “pure” variety. In this study, we developed an efficient method to authenticate A. acutiloba var. acutiloba and A. acutiloba var. sugiyamae from each other and from other Angelica species/varieties. The random amplified polymorphic DNA (RAPD) method efficiently discriminated each Angelica variety. A. acutiloba var. sugiyamae was identified via a characteristic fragment amplified by the decamer primer OPD-15. This fragment showed polymorphisms among Angelica species/varieties. The unique fragment derived from A. acutiloba var. sugiyamae was also found in one strain of A. acutiloba var. acutiloba, implying that this strain arose from outcrossing between A. acutiloba var. acutiloba and A. acutiloba var. sugiyamae. This RAPD marker technique will be useful for practical and accurate authentication among A.
    [Show full text]
  • And Elettaria Cardamomum (Cardamom) Extracts Using a Murine Macrophage Cell Line
    American International Journal of Available online at http://www.iasir.net Research in Formal, Applied & Natural Sciences ISSN (Print): 2328-3777, ISSN (Online): 2328-3785, ISSN (CD-ROM): 2328-3793 AIJRFANS is a refereed, indexed, peer-reviewed, multidisciplinary and open access journal published by International Association of Scientific Innovation and Research (IASIR), USA (An Association Unifying the Sciences, Engineering, and Applied Research) An in vitro study of the immunomodulatory effects of Piper nigrum (black pepper) and Elettaria cardamomum (cardamom) extracts using a murine macrophage cell line Anuradha Vaidya1 and Maitreyi Rathod2 1Deputy Director 1,2Symbiosis School of Biomedical Sciences (SSBS), Symbiosis International University (SIU), Symbiosis Knowledge Village, Gram- Lavale, Taluka- Mulshi, Pune 412115, Maharashtra, INDIA. Abstract: Cardamom and black pepper have been used as spices in many different cultures of the world and the medicinal properties attributed to these are extensive. Although the immunomodulatory activities of many herbs have been studied, research related to possible immunomodulatory effects of various spices on macrophages is relatively scarce. Hence in this study, we have explored the potential immunomodulatory effects of black pepper and cardamom on macrophages. We show that black pepper and cardamom extracts act as potent modulators of the macrophages in a dose-dependent “see-saw” like manner. Our findings suggest that perhaps black pepper and cardamom could be used individually or synergistically (at appropriate concentrations) as candidates for developing potential therapeutic tools to regulate the responses of the immune system depending upon the type of disease. Keywords: Immunomodulation; Black pepper; Cardamom; MTT assay; Doubling time I. INTRODUCTION Monocytes and macrophages are the central cells of the innate immune system that arise from a common myeloid progenitor in the bone marrow [1].
    [Show full text]
  • Healthy Aging: Antioxidants, Adaptogens & Cognition
    Healthy Aging: Antioxidants, Adaptogens & Cognition Karen Butler Michael Altman, CN, RH (AHG) Kieron Edwards, Ph.D. Senior Editor Herbalist Nutritionist Chief Scientific Officer Informa Markets Anthocyanins International LLC Sibelius Natural Products (SeattleCancerCareAlternatives.com) David Heber, M.D., Ph.D., FACP, FASN Katie Stage, N.D., RH (AHG) Professor Emeritus and Founding Director, Therapeutics Division Director UCLA Center for Associate Professor, Southwest Human Nutrition College of Naturopathic Medicine (SCNM) Booth #5310 Towards healthy aging Kieron Edwards PhD MBA www.sibeliusnaturalproducts.com OCTOBER 2019 1 Talk outline Booth #5310 . The trends and challenges of aging . What occurs during aging? . Theories, effects, and pathways of aging . Supporting healthy aging 2 Aging: The monster at the end of the Booth #5310 book 3 The trends and challenges of aging Booth #5310 4 What is aging? Booth #5310 . Ageing results from the impact of the accumulation of a wide variety of molecular and cellular damage over time. This leads to a gradual decrease in physical and mental capacity, a growing risk of disease, and ultimately, death. But these changes are neither linear nor consistent, and they are only loosely associated with a person’s age in years (WHO) 5 Age-related changes to health Booth #5310 . Physical aging . Sensory loss, body composition changes, osteoarthritis . Cognitive aging . Immune aging . Immunosenecence, inflammation . Cardiovascular health . CVD is still the leading cause of death in older adults . Metabolic health . Cancer . Second leading cause of death in older adults 6 Living longer and better? Booth #5310 . Human lifespan is increasing . Almost 2 years increase per decade . Age is a major risk-factor in many human diseases and conditions .
    [Show full text]
  • Smart Drugs: a Review
    International Journal for Innovation Education and Research www.ijier.net Vol:-8 No-11, 2020 Smart Drugs: A Review Sahjesh Soni, Dr Rashmi Srivastava, Ayush Bhandari Mumbai Educational Trust, India Abstracts Smart drugs can change the way our mind functions. Smart drugs are also known as nootropics, which literally means the ability to bend or shape our mind. Smart drugs are classified into two main categories. They are classified based on their pharmacological action and their availability. The stimulant category of drugs is highly used and misused. There has been a rampant increase in the sale of smart drugs, which could be attributed to the rise in competition all over the world. Two major criteria for selecting a good drug are its mechanism of action and bioavailability. Owing to the short-term benefits of smart drugs, many countries have openly accepted this concept. There is still no concrete scientific evidence backing the safety and efficacy of these drugs. Some believe that this is just a fad that will soon pass, while others believe that this is something that will revolutionize our future. Key Words: Smart drugs, Nootropics, Cognitive enhancers, Stimulants, Uses and Side effects. What are Smart Drugs? "Smart drugs" are a group of compounds that can promote brain performance. They have got a lot of attention due to our stressful lifestyle, and these drugs help to boost our memory, focus, creativity, intelligence, and motivation. The origin of the word comes from the Greek language meaning “to bend or shape the mind”.1 These chemicals have many mechanisms of action.
    [Show full text]
  • Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
    Int. J. Biol. Sci. 2018, Vol. 14 341 Ivyspring International Publisher International Journal of Biological Sciences 2018; 14(3): 341-357. doi: 10.7150/ijbs.23247 Review Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders Ghulam Hussain1,3, Azhar Rasul4,5, Haseeb Anwar3, Nimra Aziz3, Aroona Razzaq3, Wei Wei1,2, Muhammad Ali4, Jiang Li2, Xiaomeng Li1 1. The Key Laboratory of Molecular Epigenetics of MOE, Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China 2. Dental Hospital, Jilin University, Changchun 130021, China 3. Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan 4. Department of Zoology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan 5. Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science. 2-1 Hirosawa, Wako, Saitama 351-0198 Japan Corresponding authors: Professor Xiaomeng Li, The Key Laboratory of Molecular Epigenetics of Ministry of Education, Institute of Genetics and Cytology, Northeast Normal University, 5268 People's Street, Changchun, Jilin 130024, P.R. China. E-mail: [email protected] Tel: +86 186 86531019; Fax: +86 431 85579335 or Professor Jiang Li, Department of Prosthodontics, Dental Hospital, Jilin University, 1500 Tsinghua Road, Changchun, Jilin 130021, P.R. China. E-mail: [email protected] © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2017.10.09; Accepted: 2017.12.18; Published: 2018.03.09 Abstract Neurodegenerative diseases are conventionally demarcated as disorders with selective loss of neurons.
    [Show full text]
  • Neuroprotective Effect of Cannabidiol, a Non-Psychoactive Component from Cannabis Sativa, on Β-Amyloid-Induced Toxicity in PC12
    Journal of Neurochemistry, 2004, 89, 134–141 doi:10.1111/j.1471-4159.2003.02327.x Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa,onb-amyloid-induced toxicity in PC12 cells Teresa Iuvone, Giuseppe Esposito, Ramona Esposito, Rita Santamaria, Massimo Di Rosa and Angelo A. Izzo Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy )7 )4 Abstract Treatment of the cells with cannabidiol (10 )10 M) prior to Alzheimer’s disease is widely held to be associated with oxi- b-amyloid peptide exposure significantly elevated cell survival dative stress due, in part, to the membrane action of b-amyloid while it decreased ROS production, lipid peroxidation, peptide aggregates. Here, we studied the effect of cannabi- caspase 3 levels, DNA fragmentation and intracellular cal- diol, a major non-psychoactive component of the marijuana cium. Our results indicate that cannabidiol exerts a combina- plant (Cannabis sativa)onb-amyloid peptide-induced toxicity tion of neuroprotective, anti-oxidative and anti-apoptotic in cultured rat pheocromocytoma PC12 cells. Following effects against b-amyloid peptide toxicity, and that inhibition exposure of cells to b-amyloid peptide (1 lg/mL), a marked of caspase 3 appearance from its inactive precursor, reduction in cell survival was observed. This effect was pro-caspase 3, by cannabidiol is involved in the signalling associated with increased reactive oxygen species (ROS) pathway for this neuroprotection. production and lipid peroxidation, as well as caspase 3 (a key Keywords: Alzheimer’s disease, apoptosis, b-amyloid, enzyme in the apoptosis cell-signalling cascade) appearance, cannabidiol, cannabinoid, neuroprotection. DNA fragmentation and increased intracellular calcium.
    [Show full text]
  • Quality Control of Herbal Material and Phytopharmaceuticals with MS and NMR Based Metabolic Fingerprinting
    Review 763 Quality Control of Herbal Material and Phytopharmaceuticals with MS and NMR Based Metabolic Fingerprinting Authors Frank van der Kooy, Federica Maltese, Young Hae Choi, Hye Kyong Kim, Robert Verpoorte Affiliation Division of Pharmacognosy, Section of Metabolomics, Institute of Biology, Leiden University, Leiden, The Netherlands Key words Abstract areas of research such as drug discovery from nat- l" metabolic fingerprinting ! ural resources, quality control of herbal material, l" NMR Metabolic fingerprinting techniques have re- and discovering lead compounds. In this review l" MS ceived a lot of attention in recent years and the the current state of the art of metabolic finger- l" medicinal plants annual amount of publications in this field has in- printing, focussing on NMR and MS technologies l" herbal plant preparations creased significantly over the past decade. This in- will be discussed. The application of these two an- crease in publications is due to improvements in alytical tools in the quality control of herbal mate- the analytical performance, most notably in the rial and phytopharmaceuticals forms the major field of NMR and MS analysis, and the increased part of this review. Finally we will look at the fu- awareness of the different applications of this ture developments and perspectives of these two growing field. Metabolomic fingerprinting or technologies in the quality control of herbal ma- profiling is continuously being applied to new terial. Introduction These terms, notably metabolic profiling, meta- ! bolic fingerprinting and metabolomics are some- Plants have been used throughout history as the times used interchangeably. It is not our intention primary source of food, timber, fuel, and medi- to give a formal definition of metabolomics.
    [Show full text]
  • Treating Senile Dementia with Traditional Chinese Medicine
    REVIEW Treating senile dementia with traditional Chinese medicine Han Yan1 Abstract: Senile dementia is a syndrome in the elderly involving defi cits in memory and Lin Li2 cognition. There has been a long history of research and medical practice in dementia in China, Xi Can Tang1 during which the ancient Chinese people have formed a whole theory and accumulated abundant experience in the treatment of dementia. During recent decades, with new theories and tech- 1State Key Laboratory of Drug Research, Shanghai Institute of nologies being digested and integrated, progress has been made in the medical and pharmacy Materia Medica, Chinese Academy research on senile dementia in China. In this review, we will focus on the traditional opinion, of Sciences, Shanghai, China; clinical practice, and recent progress in pharmacological research in China towards the treatment 2Unilever Research China, Shanghai, China of dementia. We also discuss the potential trends of global convergence. Keywords: senile dementia, Alzheimer’s disease, vascular dementia, traditional Chinese medicine The term “senile dementia” refers to a clinical syndrome seen in the elderly charac- terized by impairment of memory and cognition. With the dramatic improvement of average life expectancy and the fast increasing of the aged population in recent years, senile dementia has become a major problem of public health. Alzheimer’s disease (AD) is the most common type of dementia, which is a pro- gressive neurodegenerative disease and has become the third greatest threat to elderly, inferior only to cardiovascular disease and cancer. Since 1907, when German surgeon Alois Alzheimer reported the fi rst case of dementia that now bears his name, great efforts have been made in attempt to discover the pathology and remedy of AD.
    [Show full text]
  • Natural Product for the Treatment of Alzheimer's Disease
    J Basic Clin Physiol Pharmacol 2017; 28(5): 413–423 Review Thanh Tung Bui* and Thanh Hai Nguyen Natural product for the treatment of Alzheimer’s disease https://doi.org/10.1515/jbcpp-2016-0147 Received September 27, 2016; accepted May 28, 2017; previously Pathogenesis of Alzheimer’s disease published online July 14, 2017 Until now, the pathogenesis of AD is not yet completely Abstract: Alzheimer’s disease (AD) is related to increas- understood. The genetic susceptibility and environmental ing age. It is mainly characterized by progressive neu- factors are responsible for late onset sporadic AD, which rodegenerative disease, which damages memory and is the most common form of the disease. Many studies cognitive function. Natural products offer many options have attempted to understand the disease mechanism and to reduce the progress and symptoms of many kinds of develop a disease-modifying drug. Two main factors are diseases, including AD. Meanwhile, natural compound responsible for the development of AD: β-amyloid protein structures, including lignans, flavonoids, tannins, poly- and abnormal tau protein, or both of them. AD is charac- phenols, triterpenes, sterols, and alkaloids, have anti- teristized by the overproduction of β-amyloid proteins (Aβ) inflammatory, antioxidant, anti-amyloidogenic, and and hyperphosphorylated Tau protein, which can lead to anticholinesterase activities. In this review, we summa- the loss of synaptic connections and neurons in the hip- rize the pathogenesis and targets for treatment of AD. We pocampus and cerebral cortex, a decline in cognitive func- also present several medicinal plants and isolated com- tion, and dementia [2]. The accumulation of β-amyloid pounds that are used for preventing and reducing symp- protein and neurofibrillary tangles have been shown in toms of AD.
    [Show full text]
  • Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction
    pharmaceutics Review Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction Maria D. Auxtero 1, Susana Chalante 1,Mário R. Abade 1 , Rui Jorge 1,2,3 and Ana I. Fernandes 1,* 1 CiiEM, Interdisciplinary Research Centre Egas Moniz, Instituto Universitário Egas Moniz, Quinta da Granja, Monte de Caparica, 2829-511 Caparica, Portugal; [email protected] (M.D.A.); [email protected] (S.C.); [email protected] (M.R.A.); [email protected] (R.J.) 2 Polytechnic Institute of Santarém, School of Agriculture, Quinta do Galinheiro, 2001-904 Santarém, Portugal 3 CIEQV, Life Quality Research Centre, IPSantarém/IPLeiria, Avenida Dr. Mário Soares, 110, 2040-413 Rio Maior, Portugal * Correspondence: [email protected]; Tel.: +35-12-1294-6823 Abstract: Late-life mild cognitive impairment and dementia represent a significant burden on health- care systems and a unique challenge to medicine due to the currently limited treatment options. Plant phytochemicals have been considered in alternative, or complementary, prevention and treat- ment strategies. Herbals are consumed as such, or as food supplements, whose consumption has recently increased. However, these products are not exempt from adverse effects and pharmaco- logical interactions, presenting a special risk in aged, polymedicated individuals. Understanding pharmacokinetic and pharmacodynamic interactions is warranted to avoid undesirable adverse drug reactions, which may result in unwanted side-effects or therapeutic failure. The present study reviews the potential interactions between selected bioactive compounds (170) used by seniors for cognitive enhancement and representative drugs of 10 pharmacotherapeutic classes commonly prescribed to the middle-aged adults, often multimorbid and polymedicated, to anticipate and prevent risks arising from their co-administration.
    [Show full text]
  • Huperzine for Use in the Treatment of Neuropathic
    (19) TZZ_Z_¥¥_T (11) EP 1 901 733 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/215 (2006.01) A61K 31/74 (2006.01) 06.04.2016 Bulletin 2016/14 A61K 9/20 (2006.01) (21) Application number: 06770999.8 (86) International application number: PCT/US2006/019985 (22) Date of filing: 23.05.2006 (87) International publication number: WO 2006/127748 (30.11.2006 Gazette 2006/48) (54) HUPERZINE FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN HUPERZIN ZUR VERWENDUNG BEI DER BEHANDLUNG VON NEUROPATHISCHEN SCHMERZEN HUPERZINE POUR SON UTILISATION DANS LE TRAITEMENT DE LA DOULEUR NEUROPATHIQUE (84) Designated Contracting States: US-A1- 2004 214 863 US-A1- 2005 065 176 AT BE BG CH CY CZ DE DK EE ES FI FR GB GR US-A1- 2005 129 783 HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR • GALEOTTI, NICOLETTA ET AL: "Antinociceptive profile of the natural cholinesterase inhibitor (30) Priority: 23.05.2005 US 683745 P huperzine A", DRUG DEVELOPMENT 04.01.2006 US 756141 P RESEARCH , 54(1), 19-26 CODEN: DDREDK; ISSN: 0272-4391, 2001, XP002632199, (43) Date of publication of application: • RAJENDRAN V ET AL: "Synthesis of more potent 26.03.2008 Bulletin 2008/13 analogues of the acetylcholinesterase inhibitor, huperzine B", BIOORGANIC AND MEDICINAL (73) Proprietor: President and Fellows of Harvard CHEMISTRY LETTERS, vol. 12, no. 11, 3 June College 2002 (2002-06-03), pages 1521-1523, Cambridge, MA 02138-3805 (US) XP002632200, ISSN: 0960-894X • DATABASECA [Online] CHEMICAL ABSTRACTS (72) Inventor: SCHACHTER, Steven, C.
    [Show full text]